Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin-Reference-Cited by-同舟云学术

Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin

Published:2019-08 Issue:2 Volume:51 Page:398-410.e5
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Andrews Sarah F.,Chambers Michael J.,Schramm Chaim A.,Plyler Jason,Raab Julie E.,Kanekiyo Masaru,Gillespie Rebecca A.,Ransier Amy,Darko Sam,Hu Jianfei,Chen Xuejun,Yassine Hadi M.,Boyington Jeffrey C.,Crank Michelle C.,Chen Grace L.,Coates Emily,Mascola John R.,Douek Daniel C.,Graham Barney S.,Ledgerwood Julie E.,McDermott Adrian B.

Funder

NIH

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference75 articles.

1. HTSeq--a Python framework to work with high-throughput sequencing data;Anders;Bioinformatics,2015

2. Immune history profoundly affects broadly protective B cell responses to influenza;Andrews;Sci. Transl. Med.,2015

3. Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans;Andrews;Sci. Immunol.,2017

4. Understanding and Manipulating Viral Immunity: Antibody Immunodominance Enters Center Stage;Angeletti;Trends Immunol.,2018

5. Defining B cell immunodominance to viruses;Angeletti;Nat. Immunol.,2017

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An explainable language model for antibody specificity prediction using curated influenza hemagglutinin antibodies;Immunity;2024-08

2. Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding;npj Vaccines;2024-07-17

3. Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38;Cell Reports;2024-07

4. Systems vaccinology identifies clinical and immunological correlates of SARS-CoV-2 vaccine response in solid-organ transplant recipients;2024-04-06

5. Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant;Expert Review of Vaccines;2024-04-02